Gennao Bio is a privately held biotechnology company focused on developing targeted nucleic acid therapeutics for oncology and rare monogenic skeletal muscle diseases
Gennao Bio is a privately held biotechnology company focused on developing targeted nucleic acid therapeutics for oncology and rare monogenic skeletal muscle diseases. Its core platform leverages a cell-penetrating antibody to non-covalently bind and deliver a range of nucleic acid payloads systemically, enabling repeat dosing and broader payload compatibility using established manufacturing processes.